Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery.
Eur J Obstet Gynecol Reprod Biol
; 45(1): 70-2, 1992 Jun 16.
Article
en En
| MEDLINE
| ID: mdl-1535604
ABSTRACT
Four patients with heavy menorrhagia, severe iron-deficiency anemia and contraindications to surgery were treated with a gonadotropin-releasing hormone agonist in a depot formulation. At 2 months of therapy they were all amenorrheic, and at 6 months the hematologic values had improved markedly. Gonadotropin-releasing hormone agonists may obviate emergency surgery in patients at high surgical risk or could constitute the first line of sequential therapeutic regimens, once general health conditions have improved.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Buserelina
/
Histerectomía
/
Menorragia
Límite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Eur J Obstet Gynecol Reprod Biol
Año:
1992
Tipo del documento:
Article
País de afiliación:
Italia